AG
ORGO icon

AmeriFlex Group’s Organogenesis Holdings ORGO Stock Holding History

AmeriFlex Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$3.61K – 1266
2025
Q2 		$3.61K Hold
1,000
– – ﹤0.01% 886
2025
Q1 		$4.32K Buy
+1,000
New +$4.04K ﹤0.01% 1025

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AmeriFlex Group's ORGO Position: Q3 2025 in Review

AmeriFlex Group sold out of Organogenesis Holdings (ORGO) in Q3 2025, closing a stake of 1,000 shares — an estimated $3.61K sold.

AmeriFlex Group first reported a position in ORGO in Q1 2025 and held it in 2 quarters. The position peaked at $4.32K in Q1 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q3 2025.

  • AmeriFlex Group reported no remaining Organogenesis Holdings position as of Q3 2025 after selling out during the quarter.
  • AmeriFlex Group sold 1,000 Organogenesis Holdings shares in Q3 2025, an estimated $3.61K.
  • AmeriFlex Group first reported a position in Organogenesis Holdings in Q1 2025 and held it in 2 quarters.
  • AmeriFlex Group's Organogenesis Holdings position peaked at $4.32K in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2025.

Based on AmeriFlex Group's 13F filing for Q3 2025, filed 12 Nov 2025.